CAS: 96829-58-2 High Purity Anabolic Raw Powder Orlistat for Lose Weight Slimming

Model NO.: 96829-58-2
Trademark: CJC
Transport Package: According to Customer′s Requirment
Origin: China
HS Code: 3001200090
Model NO.: 96829-58-2
Trademark: CJC
Transport Package: According to Customer′s Requirment
Origin: China
HS Code: 3001200090
CAS: 96829-58-2 High purity Anabolic Raw Powder Orlistat for Lose Weight Slimming
 

Orlistat Quick Details
 
Product Name: Orlistat
CAS: 96829-58-2
MF: C29H53NO5
MW: 495.73
Product Categories: Pharmaceutical Raw Materials;Miscellaneous Biochemicals;API;Antiobesity Agent;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Amino Acids & Derivatives;Heterocycles;ACTOS;Other APIs;Lipid-lowering medicine reducing weight
Mol File: 96829-58-2.mol


Orlistat Dosage and Administration

Adults

The recommended dose of orlistat is one 120 mg capsule taken with water immediately before, during or up to one hour after each main meal. If a meal is missed or contains no fat, the dose of orlistat should be omitted.

The patient should be on a nutritionally balanced, mildly hypocaloric diet that contains approximately 30 % of calories from fat. It is recommended that the diet should be rich in fruit and vegetables. The daily intake of fat, carbohydrate and protein should be distributed over three main meals.

Doses of orlistat above 120 mg three times daily have not been shown to provide additional benefit.

The effect of orlistat results in an increase in faecal fat as early as 24 to 48 hours after dosing. Upon discontinuation of therapy, faecal fat content usually returns to pre-treatment levels, within 48 to 72 hours.

Special populations

The effect of orlistat in patients with hepatic and/or renal impairment, children and elderly patients has not been studied.

There is no relevant indication for use of Venical in children.


Orlistat Usage

1. An antiobesity agent. A pancreatic lipase inhibitor. Antiobesity agent.
2. antidiabetic
3. Orlistat is an antiobesity agent. Orlistat is an pancreatic lipase inhibitor.
4. Tetrahydrolipstatin (orlistat) is a semi-synthetic derivative of lipstatin, a metabolite isolated from Streptomyces toxytricini. Tetrahydrolipstatin acts as a potent, irreversible inhibitor of pancreatic lipase. In vivo, it blocks the absorption of triglycerides while allowing fatty acid absorption. Tetrahydrolipstatin is widely used for the treatment of obesity.
5. Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost.
6. The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%). Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).


Orlistat Applications

The effectiveness of orlistat in promoting weight loss is definite, though modest. Pooled data from clinical trials suggest that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about 2-3 kilograms more than those not taking the drug over the course of a year.Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.
Orlistat is notorious for its gastrointestinal side effects (sometimes referred to as treatment effects), which can include steatorrhea (oily, loose stools). In the United States and the European Union, orlistat is available for sale without a prescription.  Generic formulations of orlistat are available in some countries.


Orlistat Image

CAS: 96829-58-2 High Purity Anabolic Raw Powder Orlistat for Lose Weight Slimming

CAS: 96829-58-2 High Purity Anabolic Raw Powder Orlistat for Lose Weight Slimming

CAS: 96829-58-2 High Purity Anabolic Raw Powder Orlistat for Lose Weight Slimming

CAS: 96829-58-2 High Purity Anabolic Raw Powder Orlistat for Lose Weight Slimming


Peptides product list 
 
Peptides
  Name Specification
T-A001 MGF 2mg/vial
T-A002 PEG MGF 2mg/vial
T-A003 CJC-1295 with DAC 2mg/vial
T-A004 CJC-1295 without DAC 2mg/vial
T-A005 PT-141 10mg/vial
T-A006 MT-1(Melanotan) 10mg/vial
T-A007 MT-2 10mg/vial
T-A008 GHRP-2 5mg/vial
T-A008 GHRP-2  10mg/vial
T-A009 GHRP-6 5mg/vial
T-A009 GHRP-6 10mg/vial
T-A010 Ipamorelin 2mg/vial
T-A011 Hexarelin 2mg/vial
T-A012 Sermorelin 2mg/vial
T-A013 Oxytocin 2mg/vial
T-A014 TB500 2mg/vial
T-A015 pentadecapeptide BPC 157 2mg/vial
T-A016 Fragment 176-191 2mg/vial
T-A017 Triptorelin 2mg/vial
T-A018 Tesamorelin 2mg/vial
T-A020 Gonadorelin 2mg/vial
T-A020 Gonadorelin 10mg/vial
T-A021 DSIP  2mg/vial
T-A022 Selank 5mg/vial
T-A023 Follistatin 344  1mg/vial
T-A024 GDF-8 1mg/vial
T-A025 ACE 031 1mg/vial
T-A026 FOLLISTATIN 314 1mg/vial

If you have any questions, you can contact me.

Nicole
Tel:+86 18872220801
CAS: 96829-58-2 High purity Anabolic Raw Powder Orlistat for Lose Weight Slimming
 

Orlistat Quick Details
 
Product Name: Orlistat
CAS: 96829-58-2
MF: C29H53NO5
MW: 495.73
Product Categories: Pharmaceutical Raw Materials;Miscellaneous Biochemicals;API;Antiobesity Agent;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Amino Acids & Derivatives;Heterocycles;ACTOS;Other APIs;Lipid-lowering medicine reducing weight
Mol File: 96829-58-2.mol


Orlistat Dosage and Administration

Adults

The recommended dose of orlistat is one 120 mg capsule taken with water immediately before, during or up to one hour after each main meal. If a meal is missed or contains no fat, the dose of orlistat should be omitted.

The patient should be on a nutritionally balanced, mildly hypocaloric diet that contains approximately 30 % of calories from fat. It is recommended that the diet should be rich in fruit and vegetables. The daily intake of fat, carbohydrate and protein should be distributed over three main meals.

Doses of orlistat above 120 mg three times daily have not been shown to provide additional benefit.

The effect of orlistat results in an increase in faecal fat as early as 24 to 48 hours after dosing. Upon discontinuation of therapy, faecal fat content usually returns to pre-treatment levels, within 48 to 72 hours.

Special populations

The effect of orlistat in patients with hepatic and/or renal impairment, children and elderly patients has not been studied.

There is no relevant indication for use of Venical in children.


Orlistat Usage

1. An antiobesity agent. A pancreatic lipase inhibitor. Antiobesity agent.
2. antidiabetic
3. Orlistat is an antiobesity agent. Orlistat is an pancreatic lipase inhibitor.
4. Tetrahydrolipstatin (orlistat) is a semi-synthetic derivative of lipstatin, a metabolite isolated from Streptomyces toxytricini. Tetrahydrolipstatin acts as a potent, irreversible inhibitor of pancreatic lipase. In vivo, it blocks the absorption of triglycerides while allowing fatty acid absorption. Tetrahydrolipstatin is widely used for the treatment of obesity.
5. Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost.
6. The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%). Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).


Orlistat Applications

The effectiveness of orlistat in promoting weight loss is definite, though modest. Pooled data from clinical trials suggest that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about 2-3 kilograms more than those not taking the drug over the course of a year.Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.
Orlistat is notorious for its gastrointestinal side effects (sometimes referred to as treatment effects), which can include steatorrhea (oily, loose stools). In the United States and the European Union, orlistat is available for sale without a prescription.  Generic formulations of orlistat are available in some countries.


Orlistat Image

CAS: 96829-58-2 High Purity Anabolic Raw Powder Orlistat for Lose Weight Slimming

CAS: 96829-58-2 High Purity Anabolic Raw Powder Orlistat for Lose Weight Slimming

CAS: 96829-58-2 High Purity Anabolic Raw Powder Orlistat for Lose Weight Slimming

CAS: 96829-58-2 High Purity Anabolic Raw Powder Orlistat for Lose Weight Slimming


Peptides product list 
 
Peptides
  Name Specification
T-A001 MGF 2mg/vial
T-A002 PEG MGF 2mg/vial
T-A003 CJC-1295 with DAC 2mg/vial
T-A004 CJC-1295 without DAC 2mg/vial
T-A005 PT-141 10mg/vial
T-A006 MT-1(Melanotan) 10mg/vial
T-A007 MT-2 10mg/vial
T-A008 GHRP-2 5mg/vial
T-A008 GHRP-2  10mg/vial
T-A009 GHRP-6 5mg/vial
T-A009 GHRP-6 10mg/vial
T-A010 Ipamorelin 2mg/vial
T-A011 Hexarelin 2mg/vial
T-A012 Sermorelin 2mg/vial
T-A013 Oxytocin 2mg/vial
T-A014 TB500 2mg/vial
T-A015 pentadecapeptide BPC 157 2mg/vial
T-A016 Fragment 176-191 2mg/vial
T-A017 Triptorelin 2mg/vial
T-A018 Tesamorelin 2mg/vial
T-A020 Gonadorelin 2mg/vial
T-A020 Gonadorelin 10mg/vial
T-A021 DSIP  2mg/vial
T-A022 Selank 5mg/vial
T-A023 Follistatin 344  1mg/vial
T-A024 GDF-8 1mg/vial
T-A025 ACE 031 1mg/vial
T-A026 FOLLISTATIN 314 1mg/vial

If you have any questions, you can contact me.

Nicole
Tel:+86 18872220801

The high black wolfberry generally refers to the black wolfberry with a particle size between 0.4-0.5 cm. The granules are full and even with low anthocyanin content. It is generally described as the size of pepper or green bean.
Chaidamu black wolfberry is one of the main building plants in Qinghai desert Gobi area, and its natural habitat conditions are generally harsh. With strong resistance, strong germination capacity, drought tolerance and cold tolerance, it can form shrubs on desert, Gobi, barren hills and barren slopes. It is a fine plant resource with good wind and sand and sand fixation to keep soil and water. It has high ecological value. It plays an important role in preventing wind and fixing sand, improving desertification soil and preserving water and soil. It has high ecological application value in ecological environment construction.
Invigorating kidney and benefiting essence and preventing cancer: Black wolfberry and red wolfberry can make up the kidney and enrich the essence, and the anthocyanin (Anthocyanosides) in black wolfberry has the effect of removing free radicals, and can also prevent cancer cells from spreading smoothly, so as to protect more healthy cells from cancer cells. It seems that the pathogenesis of breast cancer is so, so taking anthocyanins will have a good inhibitory effect on the development of breast cancer.
The oil content of Lycium ruthenium is 5.54, and 3 main fatty acids are mainly unsaturated fatty acids. The content of linoleic acid is the highest, which is 7. 4. 8. It contains 17 kinds of amino acids. The content of glutamic acid was the highest (1.14%), followed by aspartic acid (1.11%) and methionine and cystine (0.14%). Protein content was 11.5%, total sugar 34.43%, reducing sugar 33.68%, Vc 212.11mg (100g) 1, moisture 10.31%. Lycium barbarum contains a certain amount of essential fatty acids and eight kinds of essential amino acids, as well as a certain amount of VC and Ve. The most important thing is that it contains more reducing sugar and pigment, and its pigment is the active ingredient of antioxidant and delaying senescence of black fruit and wolfberry, which can play a role in delaying senescence, and also has the effect of anti radiation, which has profound potential for development.
Black Wolfberry 0.4 SpecificationsQinghai Chaidamu Black Goji Berry

Black Wolfberry 0.4 Specifications

Black Wolfberry 0.4 Specifications,Class A Bulk Black Wolfberry 0.4 Specifications,Quality Black Goji Berry 0.4 Specifications,High Grade Black Wolfberry 0.4 Specifications

Ningxia Hongqiaozhigu Technology&Development Co.,Ltd , http://www.guofuhui-ec.com

Posted on